USE OF R-(+)-2-(3-DIISOPROPYLAMINO-1-PHENYLPROPYL)-4-HYDROXY-METHYL-PHENYLISOBUTYRIC ACID ESTER HYDROGENFUMARATE FOR THE TREATMENT OF URINARY INCONTINENCE AND OTHER SPASMOGENIC DISORDERS

摘要

N,N-Diisopropyl-3-(2-acyloxy-5-hydroxymethyl)-3-phenylpropylammonium salts (I) are new. Diphenylpropylamine derivative salts of formula (I) are new. R = 1-6C alkyl, 3-10C cycloalkyl or optionally substituted phenyl; X- = residue of an organic or inorganic acid. Independent claims are included for new diphenylpropylamine derivatives of formulae (II). Q1 = COOMe; and Q2 = H or benzyl; or Q1 = CH2OH; and Q2 = H.